Applied Digital is making huge progress in building data centers for its clients. Its share price has soared, rising even faster than its quickly growing revenue. The stock's rich valuation -- at ...

Applied Digital is in the right place at the right time as AI spending ramps up. Its ability to achieve projects on time and on budget may help it win over the trust of big tech companies. A single ...

CoreWeave and Applied Digital both had strong performances in 2025. Demand for CoreWeave's AI cloud services is through the roof. Applied Digital, meanwhile, is providing the specialized buildings and ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.

CHONGQING, CHINA - SEPTEMBER 28: In this photo illustration, a hand holds a smartphone displaying the logo of Applied Digital Corporation (NASDAQ: APLD), the American company specializing in data ...

Applied Digital (APLD) posted $64.2M in Q1 revenue with 84% growth while CoreWeave (CRWV) reported $1.36B in Q3 revenue with 134% growth. CoreWeave generated $51.9M in operating income and doubled its ...

Accurate diagnosis and classification of Central Nervous System (CNS) tumors, particularly meningiomas, pose significant challenges, especially when using DNA methylation profiling data. Limited ...

The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...

Facing skepticism from analysts about whether it has the resources to take its rare disease drug to market, Applied Therapeutics is laying off almost half of the biotech's workforce to conserve its ...